4.8 Review

A glimpse at the metabolic research in China

期刊

CELL METABOLISM
卷 33, 期 11, 页码 2122-2125

出版社

CELL PRESS
DOI: 10.1016/j.cmet.2021.09.014

关键词

-

资金

  1. National Key RD Program [2018YFA0506900, 2019YFA0801701]
  2. National Science Foundation of China (NSFC) [91957119, 91854104, 31690103]

向作者/读者索取更多资源

China has seen significant economic growth and social progress, but also an increase in metabolic disorders such as diabetes. With the aging population, the prevalence of metabolic disorders is on the rise. Advances in metabolic research aim to contribute to understanding metabolism from lab to bedside.
Over the last few decades, China has witnessed a great leap in economic growth and social welfare. Unfortunately, Chinese people have also been affected by a pandemic of over-nutrition, lack of physical activity, and increasing prevalence of metabolic disorders including obesity, diabetes, non-alcohol fatty liver disease, and cardiovascular disease. For instance, China currently has the largest number of diabetic patients (-116 million) in the world. The fire of metabolic disorders is further fanned by the increased aging population, according to the survey results from the National Bureau of Statistics. On the other hand, progress in metabolic research has also made big strides. Here, we offer a glimpse at metabolic research in China, including not only its status quo but also its prospects, which aims to make significant contributions to our understanding of metabolism from bench to bedside.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据